
Related topics: Preclinical Research
An EU funded collaboration is providing integrated packages of protein kinase discovery and development services.
The Kinomed Partnership has been established to provide kinase services, including production, assay development, in silico screening, fragment library construction and medicinal chemistry. Funding has been provided by Eurostars, a European Union (EU) programme.
Olaf-Georg Issinger, director of KinaseDetect, a member of the partnership, said the goal is to develop a “service platform to provide the pharmaceutical industry with off-the-shelf three-dimensional structures of kinases and their complexes with novel lead compounds”.
KinaseDetect is working with IOTA Pharmaceuticals and SARomics Biostructures to develop the service offering.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions
© 2012 - William Reed Business Media SAS - All rights reserved. ![]()